RPG Life Sciences Limited has strategically restructured its operations by carving out its active pharmaceutical ingredients (API) business into a new, wholly-owned subsidiary, RPG Active Pharma Limited. This significant organizational change was facilitated with the expert legal guidance of Khaitan & Co, a prominent law firm.
The legal team from Khaitan & Co played a pivotal role in not only advising RPG Life Sciences during the carve-out process but also in the subsequent investment transaction involving the private equity investor, InvAscent. The experienced team was led by Managing Partner Haigreve Khaitan, alongside Partner Shishir Jose Vayttaden, Partner Aditi Singhvi, and Associate Bhaskar Vishwajeet.
Additionally, the transaction required specialized legal expertise in various domains. The real estate aspects of the deal were managed by Partner Harsh Parikh, Principal Associate Rahul Sunil Agarwal, and Associate Raghav Manojkumar Pareek. Meanwhile, the intellectual property considerations, crucial for the pharmaceutical sector, were overseen by Partner Nirupam Lodha, Senior Associate Toshani Mukherjee, and Associate Rebecca Cardoso.
This strategic move is expected to streamline RPG Life Sciences’ operations and enhance its focus on the API sector, thereby potentially attracting further investments and fostering growth. The involvement of Khaitan & Co underscores the complexity and significance of the transaction, given their comprehensive approach to addressing the multifaceted legal aspects.
For those interested in publishing their own deals, columns, or press releases, submissions can be made through the form available on the Bar & Bench website.
